Shikonin increases glucose uptake in skeletal muscle cells and improves plasma glucose levels in diabetic Goto-Kakizaki rats

Autor: Mona Wilcke, Claes-Göran Östenson, Robert I. Csikasz, Nodi Dehvari, Anette I. Öberg, Dana S. Hutchinson, Tore Bengtsson, Kamal Yassin, Irina G. Shabalina
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Blood Glucose
Male
Anatomy and Physiology
medicine.medical_treatment
Glucose uptake
Muscle Fibers
Skeletal

lcsh:Medicine
Type 2 diabetes
Mitochondrion
AMP-Activated Protein Kinases
0302 clinical medicine
Adenosine Triphosphate
Glucose homeostasis
Insulin
Phosphorylation
lcsh:Science
0303 health sciences
Multidisciplinary
Glucose Transporter Type 4
Chemistry
food and beverages
Adenosine Diphosphate
Protein Transport
medicine.anatomical_structure
030220 oncology & carcinogenesis
Medicine
Research Article
medicine.medical_specialty
Drugs and Devices
Endocrine System
Cell Line
Diabetes Mellitus
Experimental

03 medical and health sciences
Oxygen Consumption
Complementary and Alternative Medicine
Diabetes mellitus
Internal medicine
medicine
Animals
Muscle
Skeletal

Biology
030304 developmental biology
Diabetic Endocrinology
Muscle Cells
Endocrine Physiology
fungi
lcsh:R
Skeletal muscle
medicine.disease
Rats
Endocrinology
Cell culture
Metabolic Disorders
Calcium
lcsh:Q
Proto-Oncogene Proteins c-akt
Naphthoquinones
Zdroj: PLoS ONE, Vol 6, Iss 7, p e22510 (2011)
PLoS ONE
ISSN: 1932-6203
Popis: BACKGROUND: There is considerable interest in identifying compounds that can improve glucose homeostasis. Skeletal muscle, due to its large mass, is the principal organ for glucose disposal in the body and we have investigated here if shikonin, a naphthoquinone derived from the Chinese plant Lithospermum erythrorhizon, increases glucose uptake in skeletal muscle cells. METHODOLOGY/PRINCIPAL FINDINGS: Shikonin increases glucose uptake in L6 skeletal muscle myotubes, but does not phosphorylate Akt, indicating that in skeletal muscle cells its effect is medaited via a pathway distinct from that used for insulin-stimulated uptake. Furthermore we find no evidence for the involvement of AMP-activated protein kinase in shikonin induced glucose uptake. Shikonin increases the intracellular levels of calcium in these cells and this increase is necessary for shikonin-mediated glucose uptake. Furthermore, we found that shikonin stimulated the translocation of GLUT4 from intracellular vesicles to the cell surface in L6 myoblasts. The beneficial effect of shikonin on glucose uptake was investigated in vivo by measuring plasma glucose levels and insulin sensitivity in spontaneously diabetic Goto-Kakizaki rats. Treatment with shikonin (10 mg/kg intraperitoneally) once daily for 4 days significantly decreased plasma glucose levels. In an insulin sensitivity test (s.c. injection of 0.5 U/kg insulin), plasma glucose levels were significantly lower in the shikonin-treated rats. In conclusion, shikonin increases glucose uptake in muscle cells via an insulin-independent pathway dependent on calcium. CONCLUSIONS/SIGNIFICANCE: Shikonin increases glucose uptake in skeletal muscle cells via an insulin-independent pathway dependent on calcium. The beneficial effects of shikonin on glucose metabolism, both in vitro and in vivo, show that the compound possesses properties that make it of considerable interest for developing novel treatment of type 2 diabetes.
Databáze: OpenAIRE